| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.684 | 28.626 | 25.899 | 22.051 | 17.216 | 30.518 | 45.870 | 49.270 | 54.022 | 65.828 |
| Total Income - EUR | 31.687 | 28.628 | 25.903 | 22.052 | 30.803 | 40.019 | 57.650 | 66.307 | 63.554 | 65.828 |
| Total Expenses - EUR | 9.436 | 10.407 | 12.776 | 16.259 | 20.238 | 24.080 | 27.553 | 48.564 | 44.739 | 37.787 |
| Gross Profit/Loss - EUR | 22.251 | 18.221 | 13.126 | 5.793 | 10.565 | 15.939 | 30.097 | 17.743 | 18.815 | 28.041 |
| Net Profit/Loss - EUR | 21.300 | 17.362 | 11.980 | 5.573 | 10.189 | 15.772 | 29.714 | 17.324 | 18.356 | 23.574 |
| Employees | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Timvet Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.849 | 7.551 | 7.208 | 6.865 | 21.256 | 32.942 | 44.931 | 61.789 | 71.451 | 73.533 |
| Current Assets | 38.987 | 33.656 | 52.201 | 47.876 | 44.926 | 24.693 | 22.898 | 11.673 | 11.446 | 30.839 |
| Inventories | 45 | 0 | 0 | 0 | 3.377 | 1.652 | 1.270 | 5.920 | 423 | 4.660 |
| Receivables | 6.373 | 11.209 | 14.922 | 18.646 | 9.061 | 2.114 | 8.086 | 4.287 | 5.796 | 13.535 |
| Cash | 32.569 | 22.447 | 37.279 | 29.229 | 32.487 | 20.926 | 13.542 | 1.466 | 5.227 | 12.643 |
| Shareholders Funds | 44.749 | 38.215 | 49.548 | 53.862 | 63.008 | 55.796 | 43.842 | 61.302 | 79.472 | 98.914 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.088 | 2.992 | 9.861 | 879 | 3.184 | 1.839 | 23.986 | 12.193 | 3.652 | 5.482 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Timvet Medical Srl